Takeda’s Transformation and Global Leadership

Mr. Christophe Weber, President and CEO of Takeda, Japan’s largest pharmaceutical company, discusses how he is leading the transformation of this 234 year-old company into an agile, best-in-class global pharmaceutical company that puts patients at the center.

GLOBIS Top Seminar:
“Takeda’s Transformation and Global Leadership "

Date: Tuesday, November 24, 2015
Time: 19:00 - 21:00
Venue: GLOBIS Tokyo Campus
Language: English

About Takeda
Takeda Pharmaceutical is a global pharmaceutical company with a presence in more than 70 countries around the world. The company has a history spanning over 230 years and is currently the top pharmaceutical company in Japan and Asia, as well as one of the top 20 pharmaceutical firms globally. It pursues its mission to strive towards better health for people worldwide through leading innovation in medicine in four therapeutic areas: CNS, cardiovascular and metabolic diseases, gastroenterology and oncology.

Visit GLOBIS University website!


In April 2015, Christophe Weber became President and CEO of Takeda Pharmaceutical Company Limited, after joining the company as Chief Operating Officer in April 2014.

Mr. Weber is a global business leader in the pharmaceutical industry. Prior to joining Takeda, he spent 20 years at GlaxoSmithKline (GSK) in Europe, the US, and Emerging Markets. He held positions of increasing responsibility in Europe and then the USA as VP Competitive Excellence and Corporate Strategy before his appointment as Chairman and CEO of GSK France in 2003, where he maintained the profitability of GSK's largest European business.

He moved to Singapore in 2008, where he successfully restored revenue growth across 13 Asia Pacific countries. He returned to Europe in 2011 to continue his development as a global leader. He became a member of GSK headquarters’ Corporate Executive Team, and was appointed President & General Manager of GSK Vaccines and CEO of GSK Biologicals SA based in Belgium, where he had responsibility for GSK's entire global vaccines division.

Mr. Weber holds a Doctorate in pharmacy and pharmacokinetics, and earned a Master's degree in finance and pharmaceutical marketing from the University of Lyon.

Dialogue Partner

Mr. Yoshito Hori established GLOBIS Management School in 1992 and GLOBIS Capital Partners in 1996. In 2003, GLOBIS started its original MBA program which, in 2006, received accreditation from the Japanese Ministry of Education and gained “university” status. GLOBIS started a part-time MBA program in English in 2009 and a full-time MBA program in English in 2012.

A Harvard MBA graduate and former Sumitomo Corporation employee, Mr. Hori founded the Entrepreneurs’ Organization (EO) Japan Chapter in 1995 and became the first board member from Asia in charge of Asia Pacific region in 1996. He also served on the World Economic Forum (WEF)’s New Asian Leaders Executive Committee and Global Agenda Council on New Models of Leadership, as well as the Harvard Business School Alumni Board from 2005 to 2008. Currently, Mr. Hori is a board member of the Keizai Doyukai (Japan Association of Corporate Executives), and serves as co-chair of WEF’s Global Growth Companies.

In 2008, he launched the G1 Summit – a Japanese version of the WEF’s annual Davos forum. This led to the foundation of G1 Summit Institute in 2013, which Mr. Hori serves as Representative Director.

Just days after a huge earthquake struck northeast Japan in March 2011, Mr. Hori launched Project KIBOW to support the rebuilding of the disaster-affected areas. The following year Project KIBOW was incorporated as the KIBOW Foundation, which Mr. Hori serves as Representative Director.

An avid enthusiast of the Japanese game Go since age 40, Mr. Hori has been Director of the Nihon Ki-in (Japan Go Association) since June 2013.

Since October 2013, Mr. Hori has hosted a weekly TV program in Japan called Nippon Mirai Kaigi (Japan Future Conference). He has authored several books including Visionary Leaders who Create and Innovate Societies, Six Dimensions of Life, and My Personal Mission Statement.

Mr. Hori received his BS in Engineering from Kyoto University and his MBA from Harvard Business School.

He is an avid swimmer and enjoys spending time with his family, especially his five sons.

Follow him on
LinkedIn, Facebook, or Twitter.

Subscribe to the GLOBIS Insights Newsletter